PIII
P3 Health Partners Inc.
+0.19 (+2.50%)7.80USD2.6K成交股數26.2M市值–本益比(近四季)0.0股價營收比+8.6%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 386M+9% | 386M+4% | 385M+6% | 345M-9% | 356M-8% | 373M+8% | 362M+26% | 379M+15% | 388M | 347M | 288M | 329M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 32.4M | 25.5M | 35.7M | 22.1M | 23.4M | 25.0M | 27.2M | 26.6M | 27.4M | 24.4M | 33.1M | 27.2M |
| 營業利益 | 41.2M-221% | 8.2M-122% | −154M+44% | −44.2M+41% | −34.1M-22% | −38.1M-41% | −107M+216% | −31.3M+49% | −43.8M | −64.3M | −33.8M | −21.0M |
| 營業利益率 | 10.7% | 2.1% | -40.0% | -12.8% | -9.6% | -10.2% | -29.5% | -8.3% | -11.3% | -18.5% | -11.7% | -6.4% |
| 稅後淨利 | 7.4M-137% | 1.2M-106% | −75.5M+62% | −31.6M+163% | −20.4M+9% | −20.5M-20% | −46.5M+250% | −12.0M+22% | −18.7M | −25.5M | −13.3M | −9.8M |
| 淨利率 | 1.9% | 0.3% | -19.6% | -9.1% | -5.7% | -5.5% | -12.8% | -3.2% | -4.8% | -7.3% | -4.6% | -3.0% |
| 稀釋 EPS | -0.63-90% | 0.32-105% | -23.08+47% | -9.67+31% | -6.23-21% | -6.28+3040% | -15.70+12983% | -7.37+8089% | -7.86 | -0.20 | -0.12 | -0.09 |
| 稀釋股數 | 3.4M | 8.4M | 3.3M | 3.3M | 3.3M | 3.3M | 3.3M | 2.8M | 2.4M | 295M | 313M | 107M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 21.3M | 25.5M | 25.0M | 37.7M | 38.6M | 40.1M | 63.0M | 73.1M | 27.3M | 36.3M | 52.6M | 59.9M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 654M | 674M | 657M | 684M | 732M | 784M | 833M | 893M | 856M | 861M | 897M | 909M |
| 有息負債 | 98.1M | 260M | 228M | 214M | 102M | 106M | 133M | 133M | 118M | 108M | 108M | 108M |
| 總負債 | 517M | 807M | 797M | 665M | 644M | 663M | 569M | 528M | 470M | 427M | 396M | 378M |
| 股東權益 | 73.2M | −144M | −155M | −18.7M | 44.5M | 63.3M | 121M | 167M | 147M | 142M | 188M | −136M |
| 負債比 | 79.0% | 119.8% | 121.4% | 97.2% | 88.1% | 84.6% | 68.3% | 59.1% | 55.0% | 49.6% | 44.1% | 41.6% |
| 淨現金(現金 − 有息負債) | −76.8M | −234M | −203M | −176M | −63.4M | −66.0M | −70.3M | −60.0M | −90.8M | −72.0M | −55.7M | −48.3M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −27.5M-18% | – | – | – | −33.5M | – | – | −20.0M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | 0.00 | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −20.0M | – | – | – |
| 折舊攤銷 | 21.0M | 21.1M | 21.0M | 21.0M | 21.1M | 21.1M | 21.7M | 21.7M | 21.5M | 21.6M | 21.7M | 21.8M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -5.2% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 1.5B
| Capitated Revenue | 1.4B | 97.9% | -3.7% |
|---|---|---|---|
| Health Care Incentive Fees | 16.2M | 1.1% | +4456.7% |
| Health Care Care Coordination Management Fees | 10.8M | 0.7% | +2.5% |
| Health Care Clinical Fees Insurance Revenue | 3.1M | 0.2% | -48.5% |
| Health Care Patient Service 小計 | 30.1M | 2.1% | +78.6% |
| Health Care Other 小計 | 30.1M | 2.1% | +78.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.5B | -2.8% | −148M | -10.1% | -45.26 | – |
| FY2024 | 1.5B | +18.5% | −136M | -9.1% | -54.06 | −110M |
| FY2023 | 1.3B | +20.7% | −57.8M | -4.6% | -0.63 | −77.9M |
| FY2022 | 1.0B | +81.4% | −270M | -25.7% | -6.50 | −128M |
| FY2021 | 579M | +17.8% | −24.8M | -4.3% | – | −4.9M |
| FY2020 | 491M | +237.5% | −31.4M | -6.4% | – | −27.5M |
| FY2019 | 145M | – | −42.0M | -28.8% | – | −29.7M |